Thus, we tested the effect of individual RSK isoform gene knock-down in the GBM U373MG cell line and found that RSK2 can regulate invasion in these cells and in the temozolomide resistant primary patient-derived GBM cells. Here, RPS6KA3 is linked to glioblastoma.